Phenotypic implications of a co-existent haemorrhagic and thrombotic genotype

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 3, 2012, Pages 232-234

  Thachil, Jecko ^a   Martlew, Vanessa ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

factor V Leiden; haemorrhage; thrombosis; von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ARTICLE; BLEEDING; CASE REPORT; CHOLECYSTECTOMY; COLON RESECTION; DISEASE SEVERITY; ENTERITIS; EXON; FEMALE; GENE MUTATION; GENOTYPE; HEMOPHILIA; HUMAN; HYSTERECTOMY; ILEOSTOMY; PARTIAL THROMBOPLASTIN TIME; PHENOTYPE; POLYARTHRITIS; POSTOPERATIVE PERIOD; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; SPONDYLOSIS; ULCERATIVE COLITIS; VON WILLEBRAND DISEASE;

BLOOD COAGULATION; FEMALE; GENOTYPE; HEMORRHAGE; HUMANS; MIDDLE AGED; MUTATION, MISSENSE; PHENOTYPE; THROMBOSIS; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 84859422971     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834fb523     Document Type: Article

References (17)

1. James AH, Manco-Johnson MJ, Yawn BP, Dietrich JE, Nichols WL. Von Willebrand disease: key points from the 2008 National Heart, Lung, and Blood Institute guidelines. Obstet Gynecol 2009; 114:674-678.
2. Winikoff R, Lee C. Hemophilia carrier status and counseling the symptomatic and asymptomatic adolescent. J Pediatr Adolesc Gynecol 2010; 23 (6 Suppl):S43-S47.
3. Chee YL, Crawford JC, Watson HG, Greaves M. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol 2008; 140:496-504. (Pubitemid 351230081)
4. Franchini M, Veneri D, Poli G, Manzato F, Salvagno GL, Lippi G. High prevalence of inherited prothrombotic risk factors in 134 consecutive patients with von Willebrand disease. Am J Hematol 2006; 81:465-467. (Pubitemid 43787938)
5. Ahmad F, Kannan M, Yadav V, Biswas A, Saxena R. Impact of thrombogenic mutations on clinical phenotypes of von Willebrand disease. Clin Appl Thromb Hemost 2010; 16:281-287.
6. Koedam JA, Meijers JC, Sixma JJ, Bouma B. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 1988; 82:1236-1243.
7. van Dijk K, van der Bom JG, Fischer K, Grobbee DE, van den Berg HM. Do prothrombotic factors influence clinical phenotype of severe haemophilia? A review of the literature. Thromb Haemost 2004; 92:305-310. (Pubitemid 39172311)
8. Bos MHA, Meijerman DW, van der Zwaan C, Mertens K. Does activated protein C-resistant factor V contributes to thrombin generation in hemophilic plasma? J Thromb Haemost 2005; 3:522-530. (Pubitemid 41632878)
9. van't Veer C, Golden NJ, Kalafatis M, Simioni P, Bertina RM, Mann KG. An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN). Blood 1997; 90:3067-3072. (Pubitemid 27444200)
10. Schlachterman A, Schuettrumpf J, Liu JH, Furlan Freguia C, Toso R, Poncz M, et al. Factor V Leiden improves in vivo hemostasis in murine hemophilia models. J Thromb Haemost 2005; 3:2730-2737. (Pubitemid 41819802)
11. Mosnier LO, Lisman T, van den Berg HM, Nieuwenhuis HK, Meijers JC, Bouma BN. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration. Thromb Haemost 2001; 86:1035-1039. (Pubitemid 32975830)
12. Grunewald M, Grunewald A, Griesshammer M. Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia. Haemophilia 2002; 8:768-775. (Pubitemid 35446629)
13. Parker AC, Mundada LV, Schmaier AH, Fay WP. Factor V Leiden inhibits fibrinolysis in vivo. Circulation 2004; 110:3594-3598. (Pubitemid 39612576)
14. Gerling V, Lahpor JR, Buhre W. Peri-operative management of an adult patient with type 2N von Willebrand's disease scheduled for coronary artery bypass graft. Anaesthesia 2007; 62:405-408. (Pubitemid 46487254)
15. Pasi KJ, Collins PW, Keeling DM, Brown SA, Cumming AM, Dolan GC, et al. Management of vonWillebrand disease: a guideline fromtheUKHaemophilia Centre Doctors' Organization. Haemophilia 2004; 10:218-231. (Pubitemid 38584793)
16. Tripodi A, Chantarangkul V, Mannucci PM. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing. Br J Haematol 2009; 147:77-82.
17. Tripodi A, Ramenghi LA, Chantarangkul V, De Carli A, Clerici M, Groppo M, et al. Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests. Haematologica 2008; 93:1256-1259.